- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Probiotic supplement improves glycemic control in type 2 diabetes
Última actualización 6 de julio de 2026
Key finding
HbA1c decreased by 0.3%.
This study investigated the effects of a probiotic nutritional supplement on glycemic control in type 2 diabetes patients, revealing mixed results.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This study investigated the effects of a probiotic nutritional supplement on glycemic control in type 2 diabetes patients, revealing mixed results.
Clinical relevance
Understanding the role of probiotics in managing type 2 diabetes could offer new therapeutic options for patients struggling with glycemic control. If proven effective, such supplements could enhance existing treatment strategies, potentially leading to better health outcomes.
Keep in mind
Limited sample size may affect generalizability. Inconsistent results across different outcomes. Lack of long-term follow-up data.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Andreas P, Pamela C, Mina RH, et al. The impact of a probiotic nutritional supplement on glycemic control in patients with type 2 diabetes: A randomized controlled trial. Nutrition and Metabolic Insights. 2026;19:11786388251413658. doi:10.1177/11786388251413658
Efectos Principales
HbA1c decreased by 0.3% (p=0.05)
Fasting plasma glucose decreased by 14% (p=0.05)
Insulin decreased by 17% (p=0.05)
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to BeaT-2/Sugarburner and Adiponectin, C-reactive protein, Fasting Plasma Glucose (FPG), and 4 more.
This study contributes evidence to
Primary intervention
BeaT-2/Sugarburner
Primary outcomes
- Adiponectin
- C-reactive protein
- Fasting Plasma Glucose (FPG)
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
3
Related topics
7
Evidence pairs
408
Related studies
Why it is useful
- Contributes to 7 evidence relationships
- Includes primary outcome data
- Linked to 3 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Agrega evidencia relacionada a tu Evidence Tracker
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Tema de evidencia
Glycemic Control
matched_outcome
Evidencia relacionada
Tema de evidencia
HbA1c Reduction
Guardar evidencia
Core evidence
Study findings
The primary outcomes reported in this study.
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Fasting Plasma Glucose (FPG)
BeaT-2/Sugarburner → Fasting Plasma Glucose (FPG)
BeaT-2/Sugarburner → Fasting Plasma Glucose (FPG)
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
La Evidencia Sugiere
- HbA1c showed a significant decrease of 0.3%.
- Fasting plasma glucose decreased by 14%.
- Insulin levels decreased by 17%.
A quién se aplica
- Adults diagnosed with type 2 diabetes.
- Patients seeking alternative or complementary treatments.
Tener en Cuenta
- Results may not apply to all diabetes patients.
- Further research is needed to confirm findings.
- Variability in outcomes suggests a complex relationship.
Entre Líneas
- Limited sample size may affect generalizability.
- Inconsistent results across different outcomes.
- Lack of long-term follow-up data.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on BeaT-2/Sugarburner and Adipokine and Angiogenic Markers, BeaT-2/Sugarburner and Inflammatory Markers.
Relaciones de evidencia relacionadas
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
BeaT-2/Sugarburner → Inflammatory Markers
Supplements
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Incluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
Adipokine and Angiogenic Markers Evidence Hub
All studies measuring Adipokine and Angiogenic Markers
Measures Adipokine and Angiogenic Markers as a key outcome.
BeaT-2/Sugarburner Evidence Hub
All studies on BeaT-2/Sugarburner
Contributes to BeaT-2/Sugarburner evidence base.
Inflammatory Markers Evidence Hub
All studies measuring Inflammatory Markers
Measures Inflammatory Markers as a key outcome.
Recent Diabetes Research
Latest published studies
Published within the last 2 years.
Explora más en Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on BeaT-2/Sugarburner and Adiponectin
1 results
All studies on BeaT-2/Sugarburner and C-reactive protein
1 results
All studies on BeaT-2/Sugarburner
1 results
All studies measuring Adiponectin
1 results
All studies measuring C-reactive protein
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does BeaT-2/Sugarburner improve adiponectin?
BeaT-2/Sugarburner appears to improve Adiponectin.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Adiponectin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does BeaT-2/Sugarburner improve c-reactive protein?
BeaT-2/Sugarburner appears to improve C-reactive protein.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
C-reactive protein
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does BeaT-2/Sugarburner improve fasting plasma glucose (fpg)?
BeaT-2/Sugarburner appears to improve Fasting Plasma Glucose (FPG).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does BeaT-2/Sugarburner improve HbA1c?
BeaT-2/Sugarburner appears to improve HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.
